buy

Global Alpha

Global Alpha podcast EP14: US Earnings & BTC Cycles

In this episode of the Global Alpha podcast, Jonathan and Finn discuss the current state of the crypto markets and recent earnings reports from major tech companies. They analyze the mixed outcomes of earnings, the performance of key players like Palantir and Uber, and the implications of Bitcoin’s halving on market dynamics. The conversation also touches on investment strategies and the future outlook for both tech stocks and cryptocurrencies.

Balanced Portfolio

High Conviction – Add Telix Pharmaceuticals

As of August 5, 2025 (mid-morning AEST), Telix Pharmaceuticals (TLX) is trading around A$16.84–16.75, down approximately 17% from its previous close of A$20.24. This sharp intraday decline aligns closely with your noted price of $17 (assuming AUD). Below, I’ll address the reasons for this correction based on recent developments and why it still represents a strong buying opportunity to add to positions.

Global Alpha

Global Alpha podcast: US Earnings season ramps up

In this episode, the hosts discuss the current state of the market, highlighting key performers and sectors, particularly in technology and streaming services. They analyze earnings reports, emerging trends, and provide insights into high conviction stocks, especially in the defense sector. The conversation wraps up with strategic advice for investors navigating the current market landscape.

Global Alpha

Global Alpha – Buy Alibaba (BABA:NYSE)

Alibaba Group Holding Limited (NYSE:BABA), through its subsidiaries, provides technology infrastructure and marketing reach to help merchants, brands, retailers, and other businesses to engage with their users and customers in the People’s Republic of China and internationally. 

Scroll to Top